Articles related to PATIENT MONITORING

Among nearly 450,000 Scottish adults with hypertension, participants using a digital home blood pressure telemonitoring system showed lower rates of cardiovascular events, hospitalizations, and death compared with those receiving standard care over a median observation period spanning 2019 to 2022.

The FDA cleared the Dexcom Stelo Glucose Biosensor System for over-the-counter use in children ages 2 and older who do not use insulin, expanding a device previously limited to adults and supporting caregiver-supervised home glucose monitoring.

Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.

Smartwatch-derived nighttime scratching metrics correlated moderately with disease severity and short-term treatment response in a small pediatric atopic dermatitis cohort.

Algorithm-guided treatment was associated with improved remission rates in 5 of 7 randomized trials of major depressive disorder, though heterogeneity in protocols and outcome measures limited direct comparability.

“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science